Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methenamine hippurate after TURBT to prevent postoperative urinary tract infection
KCT0011589Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of methenamine hippurate in urinary tract infection (UTI) (2 arms), sponsored by Asan Medical Center. Primary endpoints: Urinary tract infection incidence rate and Adverse reaction rates. Started Mar 2026; status: completed.
02
Drugs
methenamine hippurate
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on KCT0011589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0011589.